Skip to content
Biotech For FIRE
  • Biotech
  • Holorogy
  • Investing
  • Book Review
  • News
  • About Me
  • Subscribe
  • Contact

sharebuyback

  • Home
  • sharebuyback

AMGN 4Q21 Earnings- what happens when heavily crowded short stock meets hype artists in a highly illiquid market

Posted by By biotechwarrior February 8, 2022Posted inTalking about BiotechNo Comments
AMGN is a massive biotech company - it is $130bn+ biotech giant. It is not just any giant - it is A GIANT THAT IS SQUEEZING 9% and it is…
Read More

Why YOU want buyback vs dividend and Why I want $TSLA to buy back some shares

Posted by By biotechwarrior October 7, 2021Posted inInvesting ThoughtsNo Comments
When a company is profitable and generates more cash than what to do with, CEO and the board now have to make critical decisions with respect to capital allocation -…
Read More
Recent posts
  • Pharma update: Bullish for 4Q24
  • Immunology market update (positive: $ABBV $UCB / negative: $JNJ, $NVS, $LLY, $BMY, $AMGN)
  • REGN’s CRL and its impact on wet AMD market: 2H23 Biotech/Pharma outlook
  • 2H23 Pharma/Biotech Outlook (Part. 1)
  • $RPRX: Curious case of insider activities at Royalty Pharma (CEO buying, but everyone else is selling)

Loading
Follow Us
  • Twitter
About Me
Logo
Former Biotech hedge fund analyst turned internet writer. Biotech can be fun and help with our FIRE plan. Still got a long way to go and wanted to share my journey. I am a Baker Brother wannabe. You can reach me at biotechwarrior@biotechforfire.tech
Subscribe for the latest posts

Loading
Useful Links
  • Endpoints News
  • FiercePharma
  • FierceBiotech
Copyright 2024 — Biotech For FIRE. All rights reserved. Sinatra WordPress Theme
Scroll to Top